Prexasertib Completed Phase 1 Trials for Colorectal Cancer / Metastatic Cancer / Non-Small Cell Lung Cancer (NSCLC) / Advanced Malignant Neoplasm Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02860780A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer